eTherapeutics Company
eTherapeutics focuses on the discovery of cancer and degenerative diseases of the nervous system.
Funding Status:
IPO
Industry:
Early Drug Development
Estimated Revenue:
Less than $1M
Technology:
Biotechnology, Health Care, Medical
Acquisitions Number:
1
Number Of Exists:
Post-IPO Equity
Headquarters:
Hanborough, Oxfordshire, United Kingdom
Total Funding:
112043919.0
Last Funding Date:
2022-09-30
Last Funding Type:
Post-IPO Equity
Investor Type:
Company
Employee Number:
11-50
Investors Number:
2.0
Investment Stage:
N/A
Founded Date:
2003-01-01